Cancers 2011, 3(1), 700-715; doi:10.3390/cancers3010700
Review

Involvement of COUP-TFs in Cancer Progression

email, email and * email
Received: 4 January 2011; in revised form: 25 January 2011 / Accepted: 10 February 2011 / Published: 18 February 2011
(This article belongs to the Special Issue Cancer Signaling Pathways and Crosstalk)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: The orphan receptors COUP-TFI and COUP-TFII are members of the nuclear receptor superfamily that play distinct and critical roles in vertebrate organogenesis, as demonstrated by loss-of-function COUP-TFI and/or COUP-TFII mutant mice. Although COUP-TFs are expressed in a wide range of tissues in adults, little is known about their functions at later stages of development or in organism homeostasis. COUP-TFs are expressed in cancer cell lines of various origins and increasing studies suggest they play roles in cell fate determination and, potentially, in cancer progression. Nevertheless, the exact roles of COUP-TFs in these processes remain unclear and even controversial. In this review, we report both in vitro and in vivo data describing known and suspected actions of COUP-TFs that suggest that these factors are involved in modification of the phenotype of cancer cells, notably of epithelial origin.
Keywords: orphan nuclear receptors; COUP-TFs; cancer progression; steroid hormones; cross-talk
PDF Full-text Download PDF Full-Text [385 KB, uploaded 18 February 2011 10:28 CET]

Export to BibTeX |
EndNote


MDPI and ACS Style

Boudot, A.; Le Dily, F.; Pakdel, F. Involvement of COUP-TFs in Cancer Progression. Cancers 2011, 3, 700-715.

AMA Style

Boudot A, Le Dily F, Pakdel F. Involvement of COUP-TFs in Cancer Progression. Cancers. 2011; 3(1):700-715.

Chicago/Turabian Style

Boudot, Antoine; Le Dily, François; Pakdel, Farzad. 2011. "Involvement of COUP-TFs in Cancer Progression." Cancers 3, no. 1: 700-715.

Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert